Duopharma Biotech’s Shareholders Approve Issuance of 235 Million Bonus Shares at Company’s Fully-Virtual Meeting of Members
KUALA LUMPUR, 13 August 2021 – Duopharma Biotech Berhad (“Duopharma Biotech” or
“the Company”) held a fully virtual Meeting of Members today, which saw the shareholders
voting to approve the 1-for-3 bonus share issuance which the Company had proposed on 3
May 2021.